# Advances in proton therapy technology and global clinical applications

**Authors:** Qi Zhang, Wencui Yang, Lina Tan, Xiangyu Guo, Tao Wang, Pengfei Zhu, Zhouchen Jing, Lei Ma, Jun Hou

PMC · DOI: 10.3389/fonc.2026.1718677 · Frontiers in Oncology · 2026-02-11

## TL;DR

This review discusses recent advancements in proton therapy technology and its global clinical applications, emphasizing innovations like AI and FLASH radiotherapy.

## Contribution

The paper systematically summarizes recent technological breakthroughs and global developments in proton therapy, with a focus on China's progress.

## Key findings

- Compact superconducting accelerators and pencil beam scanning are key innovations in proton therapy.
- AI is advancing proton therapy toward real-time adaptive precision radiotherapy.
- China is emerging as a significant market with advancements in proton center construction and treatment of local tumor types.

## Abstract

Proton therapy, by leveraging its unique physical characteristic of the Bragg peak, enables high-precision dose delivery to the tumor target while effectively protecting surrounding normal tissues, and has become an important representative of advanced radiotherapy. This review aims to systematically summarize key technological breakthroughs in recent years that have driven the progress of proton therapy, including compact superconducting accelerators, pencil beam scanning (PBS), image-guided proton therapy (IGPT), and the transformative ultra-high dose rate FLASH radiotherapy, while highlighting the role of artificial intelligence (AI) in advancing proton therapy toward real-time adaptive precision radiotherapy. The article also explores the global distribution and development status of proton centers, with a specific analysis of China’s notable advancements as an emerging market in center construction, equipment localization, and the treatment of characteristic local tumor types. Moving forward, it is essential to continue promoting technological integration and innovation, strengthen high-quality clinical research, and develop a more accessible, intelligent, and personalized proton therapy system to achieve broader clinical application and patient benefit.

## Full-text entities

- **Diseases:** breast cancer (MESH:D001943), xerostomia (MESH:D014987), esophageal cancer (MESH:D004938), IGPT (MESH:C564543), liver cancer (MESH:D006528), brain tumor (MESH:D001932), solid (MESH:D018250), nasopharyngeal carcinoma (MESH:D000077274), cognitive and endocrine functional impairment (MESH:D003072), metastases (MESH:D009362), thoracic and abdominal tumors (MESH:D000008), brain injury (MESH:D001930), skull base tumors (MESH:D019292), toxicities (MESH:D064420), rhabdomyosarcoma (MESH:D012208), skin cancer (MESH:D012878), sarcomas (MESH:D012509), neuroblastoma (MESH:D009447), cardiac and pulmonary toxicities (MESH:D066126), hearing impairment (MESH:D034381), medulloblastoma (MESH:D008527), non-small cell lung cancer (MESH:D002289), glioma (MESH:D005910), prostate cancer (MESH:D011471), skin toxicity (MESH:D012871), pancreatic cancer (MESH:D010190), Cancer (MESH:D009369), trismus (MESH:D014313), lung cancer (MESH:D008175), head and neck cancers (MESH:D006258)
- **Chemicals:** H (MESH:D006859), 11C, 13N (-), Proton (MESH:D011522), 15O (MESH:C000615263), oxygen (MESH:D010100), carbon (MESH:D002244)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932165/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12932165/full.md

## References

133 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932165/full.md

---
Source: https://tomesphere.com/paper/PMC12932165